Bio3 [design, build, operate] TM Platform

Design. Build. Operate.

Biomanufacturing, Engineered for Scale

At Liberation Bioindustries, the Bio³ [design, build, operate]™ Platform is our proprietary approach to unlocking biomanufacturing infrastructure — delivering global capacity for precision fermentation through a unified Design–Build–Operate model.

What Is Bio3?
A fully integrated platform that enables the rapid deployment of advanced biomanufacturing capacity, tailored to the needs of next-generation bio-based product companies.

Engineered with Purpose

Design

We partner with customers and regional stakeholders to design purpose-built fermentation facilities optimized for specific product classes — from dairy proteins and egg alternatives to advanced biomaterials and bioactives. Our engineering team draws from deep experience in large-scale fermentation and downstream processing to ensure every facility is cost-efficient, tech-agnostic, and future-ready.

Build

Liberation leads the execution of full-scale facility construction — managing procurement, permitting, construction, and commissioning. Our modular and replicable design approach enables rapid deployment and capital efficiency across geographies, whether in the U.S. heartland or global innovation zones like NEOM in Saudi Arabia.

Operate

We own and operate these facilities as a contract manufacturer, offering Biomanufacturing-as-a-Service (BaaS) to scale customer production. Through long-term partnerships and take-or-pay agreements, we give companies capital-light access to world-class fermentation and purification capacity, backed by robust quality systems, feedstock sourcing, and production reliability.

global expansion

Our Bio3 TM Facilities

With a state-of-the-art facility in the U.S. and plans for global expansion, we are positioning Liberation as a trusted manufacturing partner for companies worldwide.

Richmond, Indiana 

Our flagship manufacturing site in Richmond, Indiana, is the first commercial-scale, purpose-built precision fermentation facility of its kind. Designed for efficiency and scalability, the plant features:

  • 600,000 liters of initial fermentation capacity, with room for expansion.
  • Integrated downstream processing to optimize yields and streamline production.
  • A prime North American location, providing logistical advantages and seamless access to key markets.
  • Operations commencing in 2026

Kingdom of Saudi Arabia

Liberation Bioindustries is advancing early-stage engineering for a large-scale biomanufacturing facility in the Kingdom of Saudi Arabia, in partnership with Topian – The NEOM Food Company.

This project represents a critical step in our global expansion, supporting regional food security and sustainable production goals through precision fermentation. Together with Topian, we aim to bring scalable, innovative protein solutions to the Middle East and beyond.

Let’s unlock biotech's potential, together.

Liberation is currently open to customer inquiries, new team members, and investment discussions.

Contact Us

Get in touch with liberation

Liberation is currently open to customer inquiries, new team members, and investment discussions. Send us a message, and a member of the team will reach out.